GN
Genfit S.a.
GNFTF · OTC
$15.75 +0.00% (+$0.00)
Market Cap 693.0M €
P/E Ratio -
Div. Yield -
ROE 175.90%
Bulios Fair Price
$8.7
44.8% downside
Current Price
$15.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GNFTF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 10.59x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 47.96%
FCF growth N/A
Book val. growth N/A
Profitability
7 /100
Weak Net margin 131.38%
Op. margin 90.05%
FCF margin 40.82%
Quality
5 /100
Poor ROE 175.90%
ROA 54.43%
Asset turnover 0.41x
Debt
43 /100
Moderate Int. coverage -10.70x
Current ratio 2.00x
Net debt/EBITDA N/A
Stability
19 /100
Unstable Rev. volatility 69.93%
EPS volatility 3,412.05%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GNFTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Pascal Prigent
Employees
161
Headquarters
Loos
Upcoming events
29 SEP
Earnings
Upcoming earnings report